Xenon Pharmaceuticals Inc — Balance Sheet (NASDAQ:XENE) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics Dividends

Quarterly Annual

Total assets 189.19 M572.01 M754.15 M964.8 M798.14 M633.16 M Total liabilities 17.83 M21.97 M32.65 M36.88 M43.24 M51.4 M Total equity 171.35 M550.03 M721.5 M927.92 M754.9 M581.76 M Total liabilities & shareholders' equities 189.19 M572.01 M754.15 M964.8 M798.14 M633.16 M Total debt —————— Net debt ——————

Haberler

Xenon Pharmaceuticals hissesi 46,68 dolarla zirve yaptı

Xenon Pharmaceuticals stock hits 52-week high at $46.68

Xenon Q4 Loss Wider Than Expected, Pipeline Development in Focus

Xenon earnings loom as investors brace for Phase 3 catalyst

Wolfe Research, Xenon Pharmaceuticals hissesine alım tavsiyesi verdi

Wolfe Research initiates Xenon Pharmaceuticals stock coverage with outperform rating

Xenon Pharmaceuticals Stock Scores RS Rating Upgrade

Stifel, XEN1101’in potansiyeli nedeniyle Xenon Pharmaceuticals hedef fiyatını 66 dolara yükseltti

Stifel raises Xenon Pharmaceuticals stock price target to $66 on XEN1101 potential

Biohaven stock rating upgraded by RBC Capital on promising CNS data

Xenon Pharmaceuticals Inc. (XENE) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow (NASDAQ:XENE) 2026-01-12

Xenon Pharmaceuticals Inc. (XENE) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript